Literature DB >> 12547715

Identification of vascular lineage-specific genes by transcriptional profiling of isolated blood vascular and lymphatic endothelial cells.

Satoshi Hirakawa1, Young-Kwon Hong, Natasha Harvey, Vivien Schacht, Kant Matsuda, Towia Libermann, Michael Detmar.   

Abstract

In mammals, the lymphatic vascular system develops by budding of lymphatic progenitor endothelial cells from embryonic veins to form a distinct network of draining vessels with important functions in the immune response and in cancer metastasis. However, the lineage-specific molecular characteristics of blood vascular versus lymphatic endothelium have remained poorly defined. We isolated lymphatic endothelial cells (LECs) and blood vascular endothelial cells (BVECs) by immunomagnetic isolation directly from human skin. Cultured LECs but not BVECs expressed the lymphatic markers Prox1 and LYVE-1 and formed LYVE-1-positive vascular tubes after implantation in vivo. Transcriptional profiling studies revealed increased expression of several extracellular matrix and adhesion molecules in BVECs, including versican, collagens, laminin, and N-cadherin, and of the growth factor receptors endoglin and vascular endothelial growth factor receptor-1/Flt-1. Differential immunostains of human skin confirmed the blood vessel-specific expression of these genes. During embryonic development, endoglin expression was gradually down-regulated on lymphatic endothelium whereas vascular endothelial growth factor receptor-1 was absent from lymphatics. We also identified several genes with specific expression in LECs. These results demonstrate that some lineage-specific genes are only expressed during distinct developmental stages and they identify new molecular markers for blood vascular and lymphatic endothelium with important implications for future studies of vascular development and function.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12547715      PMCID: PMC1851142          DOI: 10.1016/S0002-9440(10)63851-5

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  42 in total

Review 1.  Mechanisms of angiogenesis and arteriogenesis.

Authors:  P Carmeliet
Journal:  Nat Med       Date:  2000-04       Impact factor: 53.440

2.  An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype.

Authors:  Jeffrey T Wigle; Natasha Harvey; Michael Detmar; Irina Lagutina; Gerard Grosveld; Michael D Gunn; David G Jackson; Guillermo Oliver
Journal:  EMBO J       Date:  2002-04-02       Impact factor: 11.598

3.  Mouse LYVE-1 is an endocytic receptor for hyaluronan in lymphatic endothelium.

Authors:  R Prevo; S Banerji; D J Ferguson; S Clasper; D G Jackson
Journal:  J Biol Chem       Date:  2001-02-20       Impact factor: 5.157

Review 4.  Lymphangiogenesis and lymphangiodysplasia: from molecular to clinical lymphology.

Authors:  M H Witte; M J Bernas; C P Martin; C L Witte
Journal:  Microsc Res Tech       Date:  2001-10-15       Impact factor: 2.769

5.  Expression of CC chemokine receptor-7 and regional lymph node metastasis of B16 murine melanoma.

Authors:  H E Wiley; E B Gonzalez; W Maki; M T Wu; S T Hwang
Journal:  J Natl Cancer Inst       Date:  2001-11-07       Impact factor: 13.506

6.  Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma.

Authors:  M Skobe; L M Hamberg; T Hawighorst; M Schirner; G L Wolf; K Alitalo; M Detmar
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

7.  Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3.

Authors:  T Mäkinen; T Veikkola; S Mustjoki; T Karpanen; B Catimel; E C Nice; L Wise; A Mercer; H Kowalski; D Kerjaschki; S A Stacker; M G Achen; K Alitalo
Journal:  EMBO J       Date:  2001-09-03       Impact factor: 11.598

8.  O-glycans on human high endothelial CD34 putatively participating in L-selectin recognition.

Authors:  Tero Satomaa; Ossi Renkonen; Jari Helin; Juha Kirveskari; Antti Mäkitie; Risto Renkonen
Journal:  Blood       Date:  2002-04-01       Impact factor: 22.113

9.  Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth.

Authors:  T Karpanen; M Egeblad; M J Karkkainen; H Kubo; S Ylä-Herttuala; M Jäättelä; K Alitalo
Journal:  Cancer Res       Date:  2001-03-01       Impact factor: 12.701

10.  Isolation and characterization of dermal lymphatic and blood endothelial cells reveal stable and functionally specialized cell lineages.

Authors:  E Kriehuber; S Breiteneder-Geleff; M Groeger; A Soleiman; S F Schoppmann; G Stingl; D Kerjaschki; D Maurer
Journal:  J Exp Med       Date:  2001-09-17       Impact factor: 14.307

View more
  154 in total

1.  Antibody-mediated delivery of VEGF-C potently reduces chronic skin inflammation.

Authors:  Simon Schwager; Silvana Renner; Teresa Hemmerle; Sinem Karaman; Steven T Proulx; Roman Fetz; Alexandra Michaela Golding-Ochsenbein; Philipp Probst; Cornelia Halin; Dario Neri; Michael Detmar
Journal:  JCI Insight       Date:  2018-12-06

2.  Endothelial cell diversity revealed by global expression profiling.

Authors:  Jen-Tsan Chi; Howard Y Chang; Guttorm Haraldsen; Frode L Jahnsen; Olga G Troyanskaya; Dustin S Chang; Zhen Wang; Stanley G Rockson; Matt van de Rijn; David Botstein; Patrick O Brown
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-08       Impact factor: 11.205

3.  Generation and characterization of telomerase-transfected human lymphatic endothelial cells with an extended life span.

Authors:  Riccardo E Nisato; Jillian A Harrison; Raphaele Buser; Lelio Orci; Chris Rinsch; Roberto Montesano; Philippe Dupraz; Michael S Pepper
Journal:  Am J Pathol       Date:  2004-07       Impact factor: 4.307

Review 4.  The new era of the lymphatic system: no longer secondary to the blood vascular system.

Authors:  Inho Choi; Sunju Lee; Young-Kwon Hong
Journal:  Cold Spring Harb Perspect Med       Date:  2012-04       Impact factor: 6.915

5.  miR-31 functions as a negative regulator of lymphatic vascular lineage-specific differentiation in vitro and vascular development in vivo.

Authors:  Deena M Leslie Pedrioli; Terhi Karpanen; Vasilios Dabouras; Giorgia Jurisic; Glenn van de Hoek; Jay W Shin; Daniela Marino; Roland E Kälin; Sebastian Leidel; Paolo Cinelli; Stefan Schulte-Merker; André W Brändli; Michael Detmar
Journal:  Mol Cell Biol       Date:  2010-05-17       Impact factor: 4.272

6.  An unexpected role of semaphorin3a-neuropilin-1 signaling in lymphatic vessel maturation and valve formation.

Authors:  Giorgia Jurisic; Hélène Maby-El Hajjami; Sinem Karaman; Alexandra M Ochsenbein; Annamari Alitalo; Shoib S Siddiqui; Carlos Ochoa Pereira; Tatiana V Petrova; Michael Detmar
Journal:  Circ Res       Date:  2012-06-20       Impact factor: 17.367

Review 7.  Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system.

Authors:  Hellmut G Augustin; Gou Young Koh; Gavin Thurston; Kari Alitalo
Journal:  Nat Rev Mol Cell Biol       Date:  2009-03       Impact factor: 94.444

8.  Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors.

Authors:  Vivien Schacht; Soheil S Dadras; Louise A Johnson; David G Jackson; Young-Kwon Hong; Michael Detmar
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

9.  Small Peptide Modulation of Fibroblast Growth Factor Receptor 3-Dependent Postnatal Lymphangiogenesis.

Authors:  David P Perrault; Gene K Lee; Sun Young Park; Sunju Lee; Dongwon Choi; Eunson Jung; Young Jin Seong; Eun Kyung Park; Cynthia Sung; Roy Yu; Antoun Bouz; Austin Pourmoussa; Soo Jung Kim; Young-Kwon Hong; Alex K Wong
Journal:  Lymphat Res Biol       Date:  2019-01-16       Impact factor: 2.589

10.  Lymphovascular invasion in breast cancer is associated with gene expression signatures of cell proliferation but not lymphangiogenesis or immune response.

Authors:  Mariko Asaoka; Santosh K Patnaik; Frank Zhang; Takashi Ishikawa; Kazuaki Takabe
Journal:  Breast Cancer Res Treat       Date:  2020-04-13       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.